Sign In
Buy LLY
$1,131.42
+6.04 (+0.537%)
At Close: Jun 05, 2026
Eli Lilly is ahead of everyone in this business, says Jim Cramer
07:51pm, Thursday, 08'th Aug 2024
'Mad Money' host Jim Cramer looks at what drove the markets higher today.
Leerink's David Risinger talks Eli Lilly seeing best trading day in a year after earnings
06:38pm, Thursday, 08'th Aug 2024
David Risinger, Leerink, joins 'Fast Money' to talk Eli Lilly earnings and the stock's response.
Excitement grows around Eli Lilly's GLP-1 drugs in Q2 earnings
06:37pm, Thursday, 08'th Aug 2024
Shares of Eli Lilly (LLY) are jumping after the company posted second quarter earnings results, beating expectations on both the top and bottom lines. The pharmaceutical giant raised its revenue outlo
After Eli Lilly's blowout quarter, Cramer says not to get too caught up in macro market trends
06:16pm, Thursday, 08'th Aug 2024
CNBC's Jim Cramer on Thursday recommended that investors not base portfolio decisions solely off of macro economic trends, like new employment data or interest rates. He discussed pharmaceutical giant
S&P 500 Gains and Losses Today: Eli Lilly Soars on Growing Demand for Weight-Loss Drugs
05:26pm, Thursday, 08'th Aug 2024
Major U.S. equities indexes rallied after jobless claims data released Thursday helped ease worries about the economy. The S&P 500 jumped 2.3%, marking the strongest daily performance for the benchmar
4 Key Takeaways From Eli Lilly's Earnings
04:55pm, Thursday, 08'th Aug 2024
Eli Lilly (LLY) shares soared Thursday, after the company's second-quarter earnings surpassed expectations on booming demand for its weight-loss drugs and executives provided updates on production cap
Calling All Morphic Holding, Inc. (MORF) Investors: Contact Bronstein, Gewirtz & Grossman, LLC To Claim Your Losses
04:00pm, Thursday, 08'th Aug 2024
NEW YORK, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating the merger between Morphic Holding, Inc. (“Morphic”) (NASDAQ: MORF) and Eli
Eli Lilly: The Next $1 Trillion Market Cap Stock?
02:31pm, Thursday, 08'th Aug 2024
Eli Lilly ( LLY ) reported strong quarterly results on Thursaday morning, with revenue increasing 36%, driven primarily by the success of Mounjaro, Zepbound, and Verzenio. The company also saw a signi
"Where Does Eli Lilly Go" After Tripling Mounjaro Sales?
02:08pm, Thursday, 08'th Aug 2024
Stocks for the health care company soared Thursday after beating on the top and bottom line and raising guidance for the rest of the year. Diane King Hall joins Alex Coffey and Jenny Horne to talk abo
Eli Lilly Narrows Gap with Novo Nordisk
01:59pm, Thursday, 08'th Aug 2024
Madison Muller, Bloomberg Health Reporter, discusses Eli Lilly earnings on Bloomberg Intelligence. -------- More on Bloomberg Television and Markets Like this video?
Why Eli Lilly Stock Just Jumped 8%
01:37pm, Thursday, 08'th Aug 2024
Powered by Mounjaro and Zepbound, Lilly announced staggering sales and earnings growth this morning. The weight loss drug business is so good, Lilly also raised its full-year sales forecast by $3 bill
Chart of the Day: Eli Lilly
01:15pm, Thursday, 08'th Aug 2024
Eli Lilly up today following earnings. The Investment Committee discuss their strategy in the health care sector.
Dow Jumps Over 500 Points; Eli Lilly Posts Upbeat Earnings
12:06pm, Thursday, 08'th Aug 2024
U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 500 points on Thursday.
Eli Lilly (LLY) Q2 Earnings Top, Mounjaro, Zepbound Drive View
11:55am, Thursday, 08'th Aug 2024
Eli Lilly (LLY) beats second-quarter estimates for earnings and sales. It raises its guidance for 2024 on strong demand for Mounjaro and Zepbound.
Eli Lilly CEO on compounded versions of weight loss drugs
11:45am, Thursday, 08'th Aug 2024
Eli Lilly CEO David Ricks joins ‘Squawk Box' to discuss the company's quarterly earnings results, which reported second-quarter earnings and revenue that blew past expectations and hiked its full-ye
